Research ArticleNew Horizons Symposium

Aerosol-Generating Procedures and Virus Transmission

Jie Li, Amnah Alolaiwat, James B Fink and Rajiv Dhand
Respiratory Care August 2022, 67 (8) 1022-1042; DOI: https://doi.org/10.4187/respcare.10160

References

  1. 1.↵
    1. Sharma A,
    2. Tiwari S,
    3. Deb MK,
    4. Marty JL
    . Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int J Antimicrob Agents 2020;56(2):106054.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Visualizing SARS-Cov-2 transmission routes and mitigation. BMJ 2021;375:e065312.
    OpenUrlFREE Full Text
  3. 3.↵
    1. Dzinamarira T,
    2. Mhango M,
    3. Dzobo M,
    4. Ngara B,
    5. Chitungo I,
    6. Makanda P,
    7. et al
    . Risk factors for COVID-19 among health care workers. A protocol for a systematic review and meta-analysis. PLoS One 2021;16(5):e0250958.
    OpenUrl
  4. 4.↵
    1. Tran K,
    2. Cimon K,
    3. Severn M,
    4. Pessoa-Silva CL,
    5. Conly J
    . Aerosol-generating procedures and risk of transmission of acute respiratory infections to health care workers: a systematic review. PLoS One 2012;7(4):e35797.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Klompas M,
    2. Baker M,
    3. Rhee C
    . What is an aerosol-generating procedure? JAMA Surg 2021;156(2):113-114.
    OpenUrl
  6. 6.↵
    Clinical questions about COVID-19: questions and answers. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html. Accessed March 12, 2022.
  7. 7.↵
    1. Crimi C,
    2. Pierucci P,
    3. Renda T,
    4. Pisani L,
    5. Carlucci A
    . High-flow nasal cannula and COVID-19: a clinical review. Respir Care 2022;67(2):227-240.
    OpenUrlAbstract/FREE Full Text
  8. 8.
    1. Kaur R,
    2. Weiss TT,
    3. Perez A,
    4. Fink JB,
    5. Chen R,
    6. Luo F,
    7. et al
    . Practical strategies to reduce nosocomial transmission to health care professionals providing respiratory care to patients with COVID-19. Crit Care 2020;24(1):571.
    OpenUrl
  9. 9.↵
    1. Ranney LM,
    2. Griffeth V,
    3. Jha KA
    . Critical supply shortages – The need for ventilators and personal equipment during the COVID-19 pandemic. N Engl J Med 2020;382(18):e41.
    OpenUrlPubMed
  10. 10.↵
    1. Elbeddini A
    . Sterilization plan of the used metered-dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage. J Pharm Policy Pract 2020;13(19):19.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Dhand R
    . Mitigating viral dispersion during respiratory support procedures in the ICU. Am J Respir Crit Care Med 2021;203(9):1051-1053.
    OpenUrl
  12. 12.↵
    1. Dhand R,
    2. Li J
    . Coughs and sneezes: their role in transmission of respiratory viral infections, including SARS-CoV-2. Am J Respir Crit Care Med 2020;202(5):651-659.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Li J,
    2. Ehrmann S
    . High-flow aerosol-dispersing versus aerosol-generating procedures. Am J Respir Crit Care Med 2020;202(8):1069-1071.
    OpenUrlCrossRefPubMed
  14. 14.
    1. Songu M,
    2. Cingi C
    . Sneeze reflex: facts and fiction. Ther Adv Respir Dis 2009;3(3):131-141.
    OpenUrlCrossRefPubMed
  15. 15.
    1. Chang AB
    . The physiology of cough. Paediatr Respir Rev 2006;7(1):2-8.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Klompas M,
    2. Milton DK,
    3. Rhee C,
    4. Baker MA,
    5. Leekha S
    . Current insights into respiratory virus transmission and potential implications for infection control programs: a narrative review. Ann Intern Med 2021;174(12):1710-1718.
    OpenUrlPubMed
  17. 17.↵
    1. Somsen GA,
    2. van Rijn C,
    3. Kooij S,
    4. Bem RA,
    5. Bonn D
    . Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission. Lancet Respir Med 2020;8(7):658-659.
    OpenUrl
  18. 18.↵
    1. Stadnytskyi V,
    2. Bax CE,
    3. Bax A,
    4. Anfinrud P
    . The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission. Proc Natl Acad Sci U S A 2020;117(22):11875-11877.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Jayaweera M,
    2. Perera H,
    3. Gunawardana B,
    4. Manatunge J
    . Transmission of COVID-19 virus by droplets and aerosols: a critical review on the unresolved dichotomy. Environ Res 2020;188:109819.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Leung NHL
    . Transmissibility and transmission of respiratory viruses. Nat Rev Microbiol 2021;19(8):528-545.
    OpenUrlPubMed
  21. 21.↵
    1. Wang CC,
    2. Prather KA,
    3. Sznitman J,
    4. Jimenez JL,
    5. Lakdawala SS,
    6. Tufekci Z,
    7. Marr LC
    . Airborne transmission of respiratory viruses. Science 2021;373(6558):eabd9149.
  22. 22.↵
    1. Lednicky JA,
    2. Lauzard M,
    3. Fan ZH,
    4. Jutla A,
    5. Tilly TB,
    6. Gangwar M,
    7. et al
    . Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients. Int J Infect Dis 2020;100:476-482.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Hui DS,
    2. Hall SD,
    3. Chan MT,
    4. Chow BK,
    5. Ng SS,
    6. Gin T,
    7. Sung JJ
    . Exhaled air dispersion during oxygen delivery via a simple oxygen mask. Chest 2007;132(2):540-546.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Hui DS,
    2. Chow BK,
    3. Lo T,
    4. Tsang OTY,
    5. Ko FW,
    6. Ng SS,
    7. et al
    . Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J 2019;53(4):1802339.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Takazono T,
    2. Yamamoto K,
    3. Okamoto R,
    4. Morimoto S,
    5. Izumikawa K,
    6. Mukae H
    . Effects of surgical masks on droplet dispersion under various oxygen delivery modalities. Crit Care 2021;25(1):89.
    OpenUrl
  26. 26.↵
    1. Dellweg D,
    2. Kerl J,
    3. Gena AW,
    4. Alsaad H,
    5. Voelker C
    . Exhalation spreading during nasal high-flow therapy at different flow rates. Crit Care Med 2021;49(7):e693-e700.
    OpenUrlCrossRef
  27. 27.
    1. Tang JW,
    2. Settles GS
    . Images in clinical medicine: coughing and aerosols. N Engl J Med 2008;359(15):e19.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.
    1. Anfinrud P,
    2. Stadnytskyi V,
    3. Bax CE,
    4. Bax A
    . Visualizing speech-generated oral fluid droplets with laser light scattering. N Engl J Med 2020;382(21):2061-2063.
    OpenUrlPubMed
  29. 29.↵
    1. Tang JW,
    2. Nicolle AD,
    3. Pantelic J,
    4. Jiang M,
    5. Sekhr C,
    6. Cheong DK,
    7. Tham KW
    . Qualitative real-time schlieren and shadowgraph imaging of human exhaled airflows: an aid to aerosol infection control. PLoS One 2011;6(6):e21392.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Harnois L,
    2. Alolaiwat A,
    3. Jing G,
    4. Fink JB,
    5. Dhand R,
    6. Li J
    . Efficacy of various mitigation devices in reducing fugitive emissions from nebulizers. Respir Care 2022;67(4):394-403.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Li J,
    2. Fink JB,
    3. Ehrmann S
    . High-flow nasal cannula for COVID-19 patients: low risk of bioaerosol dispersion. Eur Respir J 2020;55(5):2000892.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Gaeckle NT,
    2. Lee J,
    3. Park Y,
    4. Kreykes G,
    5. Evans MD,
    6. Hogan CJ Jr.
    Aerosol generation from the respiratory tract with various modes of oxygen delivery. Am J Respir Crit Care Med 2020;202(8):1115-1124.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Miller DC,
    2. Beamer P,
    3. Billheimer D,
    4. Subbian V,
    5. Sorooshian A,
    6. Campbell BS,
    7. Mosier JM
    . Aerosol risk with noninvasive respiratory support in patients with COVID-19. J Am Coll Emerg Physicians Open 2020;1(4):521-526.
    OpenUrl
  34. 34.↵
    1. McGain F,
    2. Humphries RS,
    3. Lee JH,
    4. Schofield R,
    5. French C,
    6. Keywood MD,
    7. et al
    . Aerosol generation related to respiratory interventions and the effectiveness of a personal ventilation hood. Crit Care Resusc 2020;22(3):212-220.
    OpenUrlPubMed
  35. 35.
    1. Helgeson SA,
    2. Lee AS,
    3. Lim KG,
    4. Niven AS,
    5. Patel NM
    . Particulate generation with different oxygen delivery devices. Respir Med 2021;181:106386.
    OpenUrl
  36. 36.↵
    1. Wilson NM,
    2. Marks GB,
    3. Eckhardt A,
    4. Clarke AM,
    5. Young FP,
    6. Garden FL,
    7. et al
    . The effect of respiratory activity, noninvasive respiratory support, and facemasks on aerosol generation and its relevance to COVID-19. Anaesthesia 2021;76(11):1465-1474.
    OpenUrlCrossRefPubMed
  37. 37.
    1. Bem RA,
    2. van Mourik N,
    3. Klein-Blommert R,
    4. Spijkerman IJ,
    5. Kooij S,
    6. Bonn D,
    7. Vlaar AP
    . Risk of aerosol formation during high-flow nasal cannula treatment in critically ill subjects. Respir Care 2021;66(6):891-896.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Jermy MC,
    2. Spence CJT,
    3. Kirton R,
    4. O’Donnell JF,
    5. Kabaliuk N,
    6. Gaw S,
    7. et al
    . Assessment of dispersion of airborne particles of oral/nasal fluid by high-flow nasal cannula therapy. PLoS One 2021;16(2):e0246123.
    OpenUrlCrossRefPubMed
  39. 39.
    1. Hamilton FW,
    2. Gregson FKA,
    3. Arnold DT,
    4. Sheikh S,
    5. Ward K,
    6. Brown J,
    7. et al
    ; AERATOR Group. Aerosol emission from the respiratory tract: an analysis of aerosol generation from oxygen delivery systems. Thorax 2021. [Epub Ahead of Print] 2022;77(3):276-282.
    OpenUrl
  40. 40.↵
    1. Strand-Amundsen R,
    2. Tronstad C,
    3. Elvebakk O,
    4. Martinsen T,
    5. Dybwad M,
    6. Lingaas E,
    7. Tønnessen TI
    . Quantification of aerosol dispersal from suspected aerosol-generating procedures. ERJ Open Res 2021;7(4):00206-2021.
  41. 41.↵
    1. Li J,
    2. Fink JB,
    3. Elshafei AA,
    4. Stewart LM,
    5. Barbian HJ,
    6. Mirza SH,
    7. et al
    . Placing a mask on COVID-19 patients during high-flow nasal cannula therapy reduces aerosol particle dispersion. ERJ Open Res 2021;7(1):00519-2020.
  42. 42.↵
    1. Leung CCH,
    2. Joynt GM,
    3. Gomersall CD,
    4. Wong WT,
    5. Lee A,
    6. Ling L,
    7. et al
    . Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial. J Hosp Infect 2019;101(1):84-87.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Lebreil AL,
    2. Greux V,
    3. Glenet M,
    4. Huguenin A,
    5. N'Guyen Y,
    6. Berri F,
    7. et al
    . Surfaces and air contamination by SARS-CoV-2 using high-flow nasal oxygenation or assisted mechanical ventilation system in ICU rooms of COVID-19 patients. J Infect Dis 2022;225(3):385-391.
    OpenUrl
  44. 44.↵
    1. Roca O,
    2. Pacheco A,
    3. Rodon J,
    4. Antón A,
    5. Vergara-Alert J,
    6. Armadans L,
    7. et al
    . Nasal high-flow oxygen therapy in COVID-19 patients does not cause environmental surface contamination. J Hosp Infect 2021;116:103-105.
    OpenUrl
  45. 45.↵
    1. Westafer LM,
    2. Soares WE 3rd.,
    3. Salvador D,
    4. Medarametla V,
    5. Schoenfeld EM
    . No evidence of increasing COVID-19 in health care workers after implementation of high-flow nasal cannula: a safety evaluation. Am J Emerg Med 2021;39:158-161.
    OpenUrl
  46. 46.↵
    1. Montiel V,
    2. Robert A,
    3. Robert A,
    4. Nabaoui A,
    5. Marie T,
    6. Mestre NM,
    7. et al
    . Surgical mask on top of high-flow nasal cannula improves oxygenation in critically ill COVID-19 patients with hypoxemic respiratory failure. Ann Intensive Care 2020;10(1):125.
    OpenUrl
  47. 47.↵
    1. Simonds AK,
    2. Hanak A,
    3. Chatwin M,
    4. Morrell M,
    5. Hall A,
    6. Parker KH,
    7. et al
    . Evaluation of droplet dispersion during noninvasive ventilation, oxygen therapy, nebulizer treatment, and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. Health Technol Assess 2010;14(46):131-172.
    OpenUrlPubMed
  48. 48.↵
    1. Hui DS,
    2. Chow BK,
    3. Ng SS,
    4. Chu LCY,
    5. Hall SD,
    6. Gin T,
    7. et al
    . Exhaled air dispersion distances during noninvasive ventilation via different Respironics face masks. Chest 2009;136(4):998-1005.
    OpenUrlCrossRefPubMed
  49. 49.↵
    1. Hui DS,
    2. Chow BK,
    3. Lo T,
    4. Ng SS,
    5. Ko FW,
    6. Gin T,
    7. Chan MTV
    . Exhaled air dispersion during noninvasive ventilation via helmets and a total face mask. Chest 2015;147(5):1336-1343.
    OpenUrl
  50. 50.↵
    1. Avari H,
    2. Hiebert RJ,
    3. Ryzynski AA,
    4. Levy A,
    5. Nardi J,
    6. Kanji-Jaffer H,
    7. et al
    . Quantitative assessment of viral dispersion associated with respiratory support devices in a simulated critical care environment. Am J Respir Crit Care Med 2021;203(9):1112-1118.
    OpenUrl
  51. 51.↵
    1. Winslow RL,
    2. Zhou J,
    3. Windle EF,
    4. Nur I,
    5. Lall R,
    6. Ji C,
    7. et al
    . SARS-CoV-2 environmental contamination from hospitalized patients with COVID-19 receiving aerosol-generating procedures. Thorax 2022;77(3):259-267.
    OpenUrlAbstract/FREE Full Text
  52. 52.↵
    1. Thuresson S,
    2. Fraenkel CJ,
    3. Sasinovich S,
    4. Soldemyr J,
    5. Widell A,
    6. Medstrand P,
    7. et al
    . Airborne SARS-CoV-2 in hospitals - effects of aerosol-generating procedures, HEPA filtration units, patient viral load, and physical distance. Clin Infect Dis 2022 Feb 28:ciac161.
  53. 53.↵
    1. Helgeson SA,
    2. Lim KG,
    3. Patel NM,
    4. Lee AS,
    5. Niven AS,
    6. Cheung J
    . Particle generation during positive airway pressure therapy. Sleep Med 2021;84:82-85.
    OpenUrl
  54. 54.↵
    1. Lavorini F,
    2. Usmani OS,
    3. Dhand R
    . Aerosol delivery systems for treating obstructive airway diseases during the SARS-CoV-2 pandemic. Intern Emerg Med 2021;16(8):2035-2039.
    OpenUrl
  55. 55.↵
    1. O'Neil CA,
    2. Li J,
    3. Leavey A,
    4. Wang Y,
    5. Hink M,
    6. Wallace M,
    7. et al
    ; Centers for Disease Control and Prevention Epicenters Program. Characterization of aerosols generated during patient care activities. Clin Infect Dis 2017;65(8):1335-1341.
    OpenUrlCrossRef
  56. 56.↵
    1. McGrath JA,
    2. O’Sullivan A,
    3. Bennett G,
    4. O’Toole C,
    5. Joyce M,
    6. Byrne MA,
    7. et al
    . Investigation of the quantity of exhaled aerosols released into the environment during nebulization. Pharmaceutics 2019;11(2):75.
    OpenUrl
  57. 57.↵
    1. Hui DS,
    2. Chow BK,
    3. Chu LCY,
    4. Ng SS,
    5. Hall SD,
    6. Gin T,
    7. Chan MTV
    . Exhaled air and aerosolized droplet dispersion during application of a jet nebulizer. Chest 2009;135(3):648-654.
    OpenUrlCrossRefPubMedWeb of Science
  58. 58.↵
    1. Tang JW,
    2. Kalliomaki P,
    3. Varila TM,
    4. Waris M,
    5. Koskela H
    . Nebulizers as a potential source of airborne virus. J Infect 2020;81(4):647-679.
    OpenUrlCrossRefPubMed
  59. 59.↵
    1. Chan VW,
    2. Ng HH,
    3. Rahman L,
    4. Tang A,
    5. Tang KP,
    6. Mok A,
    7. et al
    . Transmission of severe acute respiratory syndrome coronavirus 1 and severe acute respiratory syndrome coronavirus 2 during aerosol-generating procedures in critical care: a systematic review and meta-analysis of observational studies. Crit Care Med 2021;49(7):1159-1168.
    OpenUrl
  60. 60.↵
    1. Loeb M,
    2. McGeer A,
    3. Henry B,
    4. Ofner M,
    5. Rose D,
    6. Hlywka T,
    7. et al
    . SARS among critical care nurses, Toronto. Emerg Infect Dis 2004;10(2):251-255.
    OpenUrlCrossRefPubMedWeb of Science
  61. 61.↵
    1. Fink JB,
    2. Ehrmann S,
    3. Li J,
    4. Dailey P,
    5. McKiernan P,
    6. Darquenne C,
    7. et al
    . Reducing aerosol-related risk of transmission in the era of COVID-19: an interim guidance endorsed by the International Society of Aerosols in Medicine. J Aerosol Med Pulm Drug Deliv 2020;33(6):300-304.
    OpenUrlPubMed
  62. 62.↵
    1. Swanson CS,
    2. Dhand R,
    3. Cao L,
    4. Ferris J,
    5. Elder CS,
    6. He Q
    . Microbiome-based source identification of microbial contamination in nebulizers used by in-patients. J Hosp Infect h2022;122:157-161.
    OpenUrl
  63. 63.↵
    1. Swanson CS,
    2. Dhand R,
    3. Cao L,
    4. Ferris J,
    5. Elder CS,
    6. He Q
    . Microbiome profiles of nebulizers in hospital use. J Aerosol Med Pulm Drug Deliv 2022. [Epub ahead of print].
  64. 64.↵
    1. Woods JA
    . Evidence-based treatment during the SARS-CoV-2 pandemic: identifying the knowns and unknowns of nebulization. J Am Pharm Assoc 2021;61(2):e55-e56.
    OpenUrl
  65. 65.↵
    1. Li J,
    2. Alolaiwat A,
    3. Harnois L,
    4. Fink JB,
    5. Dhand R
    . Mitigating fugitive aerosols during aerosol delivery via high-flow nasal cannula devices. Respir Care 2022;67(4):404-414. [Epub ahead of print].
    OpenUrlAbstract/FREE Full Text
  66. 66.↵
    1. Wilson J,
    2. Carson G,
    3. Fitzgerald S,
    4. Llewelyn MJ,
    5. Jenkins D,
    6. Parker S,
    7. et al
    ; members of the Independent High Risk AGP Review Panel. Are medical procedures that induce coughing or involve respiratory suctioning associated with increased generation of aerosols and risk of SARS-CoV-2 infection? A rapid systematic review. J Hosp Infect 2021;116:37-46.
    OpenUrl
  67. 67.↵
    1. Ling L,
    2. Gomersall CD
    . Potential aerosol generation by bronchoscopy and intubation: another piece in the puzzle. Chest 2020;158(6):2251-2252.
    OpenUrl
  68. 68.↵
    1. Heinzerling A,
    2. Stuckey MJ,
    3. Scheuer T,
    4. Xu K,
    5. Perkins KM,
    6. Resseger H,
    7. et al
    . Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient - Solano County, California, February 2020. MMWR Morb Mortal Wkly Rep 2020;69(15):472-476.
    OpenUrlPubMed
  69. 69.↵
    1. Doggett N,
    2. Chow C,
    3. Mubareka S
    . Characterization of experimental and clinical bioaerosol generation during potential aerosol-generating procedures. Chest 2020;158(6):2467-2473.
    OpenUrl
  70. 70.↵
    1. Brown J,
    2. Gregson FKA,
    3. Shrimpton A,
    4. Cook TM,
    5. Bzdek BR,
    6. Reid JP,
    7. Pickering AE
    . A quantitative evaluation of aerosol generation during tracheal intubation and extubation. Anaesthesia 2021;76(2):174-181.
    OpenUrlCrossRefPubMed
  71. 71.↵
    1. Dhillon RS,
    2. Rowin WA,
    3. Humphries RS,
    4. Kevin K,
    5. Ward JD,
    6. Phan TD,
    7. et al
    ; Clinical Aerosolization Study Group. Aerosolization during tracheal intubation and extubation in an operating theater setting. Anaesthesia 2021;76(2):182-188.
    OpenUrlPubMed
  72. 72.↵
    1. Reddy C,
    2. Sethi J,
    3. Balwan A,
    4. Iravani A,
    5. Ansari S,
    6. Kelly K
    . Aerosol generation during bronchoscopy (abstract). J Bronchol Intervent Pulmonol 2021.
  73. 73.↵
    1. Chan MTV,
    2. Chow BK,
    3. Lo T,
    4. Ko FW,
    5. Ng SS,
    6. Gin T,
    7. Hui DS
    . Exhaled air dispersion during bag-mask ventilation and sputum suctioning - Implications for infection control. Sci Rep 2018;8(1):198.
    OpenUrl
  74. 74.↵
    1. Begley JL,
    2. Lavery KE,
    3. Nickson CP,
    4. Brewster DJ
    . The aerosol box for intubation in coronavirus disease 2019 patients: an in situ simulation crossover study. Anaesthesia 2020;75(8):1014-1021.
    OpenUrlCrossRefPubMed
  75. 75.↵
    1. Fong S,
    2. Li E,
    3. Violato E,
    4. Reid A,
    5. Gu Y
    . Impact of aerosol box on intubation during COVID-19: a simulation study of normal and difficult airways. Can J Anaesth 2021;68(4):496-504.
    OpenUrl
  76. 76.↵
    1. Nestor CC,
    2. Wang S,
    3. Irwin MG
    . Are tracheal intubation and extubation aerosol-generating procedures? Anaesthesia 2021;76(2):151-155.
    OpenUrl
  77. 77.↵
    1. Berges AJ,
    2. Lina IA,
    3. Ospino R,
    4. Tsai HW,
    5. Brenner MJ,
    6. Pandian V,
    7. et al
    . Quantifying viral particle aerosolization risk during tracheostomy surgery and tracheostomy care. JAMA Otolaryngol Head Neck Surg 2021;147(9):797-803.
    OpenUrl
  78. 78.↵
    1. Li J,
    2. Schoenrock C,
    3. Fink JB
    . Aerosol particle concentrations with different oxygen devices and interfaces for spontaneous breathing patients with tracheostomy: a randomized crossover trial. ERJ Open Res 2021;7(4):00486-2021.
  79. 79.↵
    1. Hull JH,
    2. Lloyd JK,
    3. Cooper BG
    . Lung function testing in the COVID-19 endemic. Lancet Respir Med 2020;8(7):666-667.
    OpenUrl
  80. 80.↵
    1. Wilson KC,
    2. Kaminsky DA,
    3. Michaud G,
    4. Sharma S,
    5. Nici L,
    6. Folz RJ,
    7. et al
    . Restoring pulmonary and sleep services as the COVID-19 pandemic lessens. From an Association of Pulmonary, Critical Care, and Sleep Division directors and American Thoracic Society–coordinated task force. Ann Am Thorac Soc 2020;17(11):1343-1351.
    OpenUrl
  81. 81.↵
    1. Sheikh S,
    2. Hamilton FW,
    3. Nava GW,
    4. Gregson FK,
    5. Arnold DT,
    6. Riley C,
    7. et al
    ; AERATOR Group. Are aerosol generated during lung function testing in patients and healthy volunteers? Results from the AERATOR study. Thorax 2022;77(3):292-294.
    OpenUrlAbstract/FREE Full Text
  82. 82.
    1. Li J,
    2. Jing G,
    3. Fink JB,
    4. Porszasz J,
    5. Moran EM,
    6. Kiourkas RD,
    7. et al
    . Airborne particulate concentrations during and after pulmonary function testing. Chest 2021;159(4):1570-1574.
    OpenUrlCrossRefPubMed
  83. 83.
    1. Helgeson SA,
    2. Lim KG,
    3. Lee AS,
    4. Niven AS,
    5. Patel NM
    . Aerosol generation during spirometry. Ann Am Thorac Soc 2020;17(12):1637-1639.
    OpenUrlCrossRefPubMed
  84. 84.↵
    1. Tomisa G,
    2. Horváth A,
    3. Farkas Á,
    4. Nagy A,
    5. Kis E,
    6. Tamási L
    . Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load. J Hosp Infect 2021;118:7-14.
    OpenUrl
  85. 85.↵
    1. Sajgalik P,
    2. Garzona-Navas A,
    3. Csécs I,
    4. Askew JW,
    5. Lopez-Jimenez F,
    6. Niven AS,
    7. et al
    . Characterization of aerosol generation during various intensities of exercise. Chest 2021;160(4):1377-1387.
    OpenUrl
  86. 86.↵
    1. Helgeson SA,
    2. Lee AS,
    3. Patel NM,
    4. Taylor BJ,
    5. Lim KG,
    6. Niven AS
    . Cardiopulmonary exercise and the risk of aerosol generation while wearing a surgical mask. Chest 2021;159(4):1567-1569.
    OpenUrl
  87. 87.↵
    1. Helgeson SA,
    2. Taylor BJ,
    3. Lim KG,
    4. Lee AS,
    5. Niven AS,
    6. Patel NM
    . Characterizing particulate generation during cardiopulmonary rehabilitation classes with patients wearing procedural masks. Chest 2021;160(2):633-641.
    OpenUrl
  88. 88.↵
    1. Garzona-Navas A,
    2. Sajgalik P,
    3. Csécs I,
    4. Askew JW,
    5. Lopez-Jimenez F,
    6. Niven AS,
    7. et al
    . Mitigation of aerosols generated during exercise testing with a portable high-efficiency particulate air filter with fume hood. Chest 2021;160(4):1388-1396.
    OpenUrl
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...